These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35337961)

  • 1. New therapy strategies in the management of breast cancer.
    Yardim-Akaydin S; Karahalil B; Baytas SN
    Drug Discov Today; 2022 Jun; 27(6):1755-1762. PubMed ID: 35337961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer.
    Müller V; Oliveira-Ferrer L; Steinbach B; Pantel K; Schwarzenbach H
    Mol Oncol; 2019 May; 13(5):1137-1149. PubMed ID: 30803129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
    Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
    Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
    Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non-Coding RNA
    Cantile M; Di Bonito M; Cerrone M; Collina F; De Laurentiis M; Botti G
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.
    Zhao W; Geng D; Li S; Chen Z; Sun M
    Cancer Med; 2018 Mar; 7(3):842-855. PubMed ID: 29473328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes and exosomal RNAs in breast cancer: A status update.
    Lakshmi S; Hughes TA; Priya S
    Eur J Cancer; 2021 Feb; 144():252-268. PubMed ID: 33373870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer: Current Molecular Therapeutic Targets and New Players.
    Nagini S
    Anticancer Agents Med Chem; 2017; 17(2):152-163. PubMed ID: 27137076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
    Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes.
    Jahangiri L; Ishola T
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing therapeutic resistance in breast cancer: from the lncRNAs perspective.
    Peng L; Jiang J; Tang B; Nice EC; Zhang YY; Xie N
    Theranostics; 2020; 10(23):10360-10377. PubMed ID: 32929354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
    Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
    J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.
    Kishore C; Karunagaran D
    Mol Cell Biochem; 2022 Jun; 477(6):1817-1828. PubMed ID: 35332394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into long non-coding RNAs in breast cancer: Biological functions and therapeutic prospects.
    Wang MQ; Zhu WJ; Gao P
    Exp Mol Pathol; 2021 Jun; 120():104640. PubMed ID: 33878314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
    Mirzaei S; Paskeh MDA; Hashemi F; Zabolian A; Hashemi M; Entezari M; Tabari T; Ashrafizadeh M; Raee P; Aghamiri S; Aref AR; Leong HC; Kumar AP; Samarghandian S; Zarrabi A; Hushmandi K
    Life Sci; 2022 Jan; 288():119948. PubMed ID: 34520771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p.
    Zhang S; Wang B; Xiao H; Dong J; Li Y; Zhu C; Jin Y; Li H; Cui M; Fan S
    Thorac Cancer; 2020 Jul; 11(7):1801-1816. PubMed ID: 32374522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.